Interventions for preventing infection in nephrotic syndrome

Area of Science:

• Nephrology
• Pediatrics
• Infectious Disease Prevention

Background:

• Infection is a major complication in nephrotic syndrome, particularly in children, leading to significant morbidity and mortality.
• Various prophylactic measures are used, but their scientific rigor and efficacy remain unclear.
• Evidence-based recommendations for infection prevention in nephrotic syndrome are lacking.

Purpose of the Study:

• To evaluate the benefits and harms of prophylactic interventions for reducing infection risk in pediatric and adult nephrotic syndrome patients.
• To synthesize current evidence on the effectiveness of different prophylactic strategies.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) and quasi-RCTs.
• Searched multiple databases including Cochrane, MEDLINE, EMBASE, and Chinese databases up to February 2012.
• Included studies comparing any prophylactic intervention (pharmacological or non-pharmacological) against baseline treatment.

Main Results:

• Twelve studies involving 762 children with nephrotic syndrome were identified; no adult studies were found.
• Intravenous immunoglobulin (IVIG), thymosin, oral transfer factor, BCG vaccine, Huangqi granules, and TIAOJINING showed potential benefits in reducing infection risk.
• Mannan peptide tablet and polyvalent bacterial vaccine did not demonstrate superiority over baseline treatment. No serious adverse events were reported.

Conclusions:

• Certain interventions like IVIG, thymosin, and BCG vaccine may help prevent infections in children with nephrotic syndrome without significant adverse events.
• The overall methodological quality of the included studies was poor, with small sample sizes and limited geographic representation (all from China).
• Strong evidence supporting the routine use of these prophylactic interventions is currently insufficient, highlighting the need for high-quality research.